Home
>
National Drug Code (NDC)
>
Cytogam
Cytogam - 44206-532-11 - (Human Cytomegalovirus Immune Globulin)
Drug Information of Cytogam
| Product NDC: | 44206-532 |
| Proprietary Name: | Cytogam |
| Non Proprietary Name: | Human Cytomegalovirus Immune Globulin |
| Active Ingredient(s): | 50 mg/mL & nbsp; Human Cytomegalovirus Immune Globulin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cytogam
| Product NDC: | 44206-532 |
| Labeler Name: | CSL Behring AG |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103189 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090106 |
Package Information of Cytogam
| Package NDC: | 44206-532-11 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (44206-532-11) > 50 mL in 1 VIAL, GLASS (44206-532-90) |
NDC Information of Cytogam
| NDC Code | 44206-532-11 |
| Proprietary Name | Cytogam |
| Package Description | 1 VIAL, GLASS in 1 CARTON (44206-532-11) > 50 mL in 1 VIAL, GLASS (44206-532-90) |
| Product NDC | 44206-532 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Human Cytomegalovirus Immune Globulin |
| Dosage Form Name | LIQUID |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090106 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring AG |
| Substance Name | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] |
